A. Boehler (Zurich, Switzerland), J. Gottlieb (Hannover, Germany)
Effect of low molecular weight heparins on the development of obliterative airway desease in the rat tracheal transplant model
J. Fillinger, I. Horvath, B. Antus (Budapest, Hungary)
|  |
Non-terminal lung function measurements in mice
S. De Vleeschauwer, M. Rinaldi, B. Vanaudenaerde, R. Vos, W. Janssens, G. Verleden (Leuven, Belgium)
|  |
Lung function in intubated mice can be measured repeatedly
S. De Vleeschauwer, M. Rinaldi, B. Vanaudenaerde, R. Vos, W. Janssens, G. Verleden (Leuven, Belgium)
| |
Better lung protection following death due to rapid exsanguination in rats
K. Bostanci, B. Karakoyun lacin, M. Yuksel, F. Ercan, M. Yuksel, H. F. Batirel (Istanbul, Turkey)
| |
Ciliary function in paediatric non cystic fibrosis (CF) lung transplant recipients
B. Thomas, P. Aurora, H. Spencer, M. Elliott, R. Hirst, A. Rutman, C. O‘Callaghan (Leicester, London, United Kingdom)
| |
Paediatric lung transplantation: a single center experience in France
V. Boussaud, C. Amrein, P. Chevalier, R. Guillemain, R. Souilamas, F. Barthes-Le Pimpec, J. N. Fabiani (Paris, France)
| |
High emergency lung transplantation in France: results after one year experience
V. Boussaud, I. Danner-Boucher, H. Mal, C. Dromer, C. Pison, M. Reynaud-Gaubert, R. Kessler, F. Philit, M. Stern (Paris, Nantes, Pessac, Grenoble, Marseille, Strasbourg, Lyon, Suresnes, France)
| |
Evaluation of pulmonary arterial pressure in lung transplant candidates: transthoracic echocardiography versus right heart catheterization
J. Mazza-Stalder, F. Lador, P. M. Soccal, J. D. Aubert (Lausanne, Switzerland)
| |
A retrospective analysis of our lung transplant cohort for the dichotomy within bronchiolitis obliterans syndrome and azithromycin therapy
B. Vanaudenaerde, R. Vos, A. Ottevaere, S. De Vleeschauwer, A. Willems-Widyastuti, D. Van raemdonck, L. Dupont, G. Verleden (Leuven, Belgium)
| |
Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection
F. Lunardi, M. Loy, F. Braccioni, E. Balestro, F. Rea (Padua, Italy)
| |
The role of EBV DNAemia in the assessment of post-transplant lymphoproliferative disorders (PTLD)
F. Baldanti, F. Bini, V. Conio, V. Rognoni, A. Cascina, C. Lastoria, T. Oggionni, F. Meloni (Pavia, Italy)
| |
Indoleamine 2,3-dioxygenase in lung allograft tolerance
F. Bini, S. Giuliano, N. Solari, P. Draghi, M. Pappalettera, A. Bardoni, R. Salvini, A. Fietta, M. Agnesi, F. Meloni (Pavia, Milano, Italy)
| |
Lung clearance index is reproducible and close to normal in stable cystic fibrosis patients post bilateral lung transplant
N. Bell, A. Horsley, K. Macleod, P. Reid, A. Greening, P. Corris, J. A. Innes, A. Fisher (Edinburgh, Newcastle, United Kingdom)
| |
Prognostic factors in patients with end stage idiopathic pulmonary fibrosis awaiting lung transplantation
G. Marulli, E. Balestro, F. Di Chiara, M. Rossi, M. Loy, E. Perissinotto, F. Calabrese, M. Saetta, F. Rea (Padova, Italy)
| |
Combined bilateral lung and pancreatic islets transplantation from the same donor in two patients with cystic fibrosis
A. Olland, L. Kessler, S. Hirschy, M. Vasilescu, P. E. Falcoz, N. Santelmo, E. Kochetkova, R. Kessler, G. Massard (Strasbourg, France)
| |
Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients
E. Bargagli, A. Fossi, A. Prasse, R. M. Refini, C. Olivieri, D. Bennett, R. Filippi, L. Voltolini, J. Muller-Quernheim, P. Rottoli (siena, Italy; Freiburg, Germany)
| |